Skip to main content
Nutricircle Limited logo

Nutricircle Limited — Investor Relations & Filings

Ticker · 530219 ISIN · INE536C01029 BSE.NS Manufacturing
Open in API
Filings indexed 7 across all filing types
Latest filing 2026-05-26 Regulatory Filings
Country IN India
Listing BSE.NS 530219

About Nutricircle Limited

https://nutricircle.in

Nutricircle Limited specializes in the research, development, and commercialization of nutritional products and health supplements. The company focuses on formulating science-based solutions intended to support preventive healthcare and general wellness. Its core activities involve the creation of plant-based proteins, dietary supplements, and functional food components tailored for health-conscious demographics. By utilizing research-driven methodologies, the organization develops products aimed at addressing nutritional deficiencies and supporting metabolic health. The company emphasizes the integration of natural ingredients with contemporary nutritional science to provide standardized health solutions.

Recent filings

Filing Released Lang Actions
Enclosed herewith Reg 24 A -Annual Secretarial Compliance report for the Year ended 31/03/2026
Regulatory Filings Classification · 75% confidence The document is a submission to the stock exchange consisting of the Annual Secretarial Compliance Report prepared under Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It contains no financial statements or management discussion of results, but rather a compliance certificate and details of regulatory adherence. This is a regulatory compliance filing and does not fit into financial report categories like 10-K, IR, ER, etc. It falls under the general “Regulatory Filings” category.
2026-05-26 English
Enclosed herewith Statement of Deviation & Variation for the Quarter ended 31/03/2026
Regulatory Filings Classification · 76% confidence The document is a stock exchange filing to disclose the quarterly statement of deviations or variations in utilization of funds raised under a preferential issue, made under SEBI LODR Regulation 32. It contains compliance tables and actual utilization data, but it is not a financial report (10-K, IR) or a capital raise announcement, nor is it an executive change, earnings release, or AGM material. It is a regulatory compliance disclosure, so it best fits the “Regulatory Filings” category (RNS).
2026-05-26 English
Enclosed herewith Disclosure relating to Appointment of Internal Auditor For FY 2026-27
Interim / Quarterly Report Classification · 88% confidence The document is a Board Meeting Outcome filed with the BSE under SEBI Listing Regulations 30 and 33, enclosing complete audited financial results (income statement, balance sheet, cash flows) for the quarter and year ended 31 March 2026. It contains substantive financial statements for a period shorter than a full fiscal year (quarterly results), not merely an announcement. Therefore it qualifies as an Interim/Quarterly Report. FY 2026
2026-05-26 English
Financial result for the Quarter and year ended 31/03/2026
Interim / Quarterly Report Classification · 91% confidence The document is a notification under SEBI Regulations 30 & 33 of the Board meeting outcome and contains the full audited financial results (statement of profit & loss, assets & liabilities, cash flows) for the quarter and year ended March 31, 2026. It is more than just key highlights and includes substantive financial statements, which matches our definition of an Interim / Quarterly Report rather than an Earnings Release or Annual Report. FY 2026
2026-05-26 English
Board Meeting Outcome for the Audited Financial result For The Quarter And Year Ended March 31, 2026.
Interim / Quarterly Report Classification · 90% confidence The document is a SEBI Listing Regulation 30 & 33 filing disclosing the audited financial results for the quarter and year ended March 31, 2026, including full P&L, balance sheet, cash flow statements and auditor’s report. It is not an Annual Report (10-K) nor a mere publication announcement; it contains substantive financial data beyond a summary. It matches the definition of an Interim/Quarterly Report (IR). FY 2026
2026-05-26 English
Nutricircle Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 ,inter alia, to consider and approve BOARD MEETING DATED 26.05.2026
Regulatory Filings Classification · 80% confidence The document is a statutory notification to BSE under SEBI LODR Regulation 29, informing about the date of the Board Meeting to consider and approve audited financial results and other agenda items. It does not contain the actual financial results nor is it announcing a corporate action like dividends or a change in management. It serves as a regulatory filing notification (a general compliance announcement). Therefore, it falls under the fallback category of Regulatory Filings (RNS).
2026-05-20 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.